Literature DB >> 8475878

Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo.

T S Rector1, S H Kubo, J N Cohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8475878     DOI： 10.1016/0002-9149(93)90582-w

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  102 in total

1.  Maximum daily 6 minutes of activity: an index of functional capacity derived from actigraphy and its application to older adults with heart failure.

Authors:  Jason Howell; B Michelle Strong; Jenny Weisenberg; Anagha Kakade; Qian Gao; Paul Cuddihy; Susan Delisle; Stan Kachnowski; Mathew S Maurer
Journal:  J Am Geriatr Soc       Date:  2010-03-30       Impact factor: 5.562

2.  Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony.

Authors:  Dominique Auger; Gabe B Bleeker; Matteo Bertini; See H Ewe; Rutger J van Bommel; Tomasz G Witkowski; Arnold C T Ng; Lieselot van Erven; Martin J Schalij; Jeroen J Bax; Victoria Delgado
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

3.  Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.

Authors:  P Kiès; C Leclercq; G B Bleeker; C Crocq; S G Molhoek; C Poulain; L van Erven; M Bootsma; K Zeppenfeld; E E van der Wall; J-C Daubert; M J Schalij; J J Bax
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

4.  Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.

Authors:  Rebecca Napier; Steven E McNulty; David T Eton; Margaret M Redfield; Omar AbouEzzeddine; Shannon M Dunlay
Journal:  JACC Heart Fail       Date:  2018-06-06       Impact factor: 12.035

Review 5.  Heart failure treatments: issues of safety versus issues of quality of life.

Authors:  J Feenstra; J Lubsen; D E Grobbee; B H Stricker
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

6.  Ventricular pacing site separation by cardiac computed tomography: validation for the prediction of clinical response to cardiac resynchronization therapy.

Authors:  S Modi; Raymond Yee; David Scholl; John Stirrat; Jorge A Wong; Carmen Lydell; Vamshi Kotha; Lorne J Gula; Allan C Skanes; Peter Leong-Sit; David McCarty; Maria Drangova; James A White
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-29       Impact factor: 2.357

7.  Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial.

Authors:  S D Hutcheon; N D Gillespie; I K Crombie; A D Struthers; M E T McMurdo
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

8.  Health-related quality of life in unselected outpatients with heart failure across Spain in two different health care levels. Magnitude and determinants of impairment: the INCA study.

Authors:  Beatriz de Rivas; Gaietà Permanyer-Miralda; Carlos Brotons; Joaquín Aznar; Eduardo Sobreviela
Journal:  Qual Life Res       Date:  2008-10-15       Impact factor: 4.147

9.  Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation.

Authors:  Jeremiah G Allen; Eric S Weiss; Justin M Schaffer; Nishant D Patel; Susan L Ullrich; Stuart D Russell; Ashish S Shah; John V Conte
Journal:  J Heart Lung Transplant       Date:  2009-10-17       Impact factor: 10.247

10.  Psychosocial determinants for frequent primary health care utilisation in patients with heart failure.

Authors:  Martin Scherer; Wolfgang Himmel; Michael M Kochen; Janka Koschack; Dirk Ahrens; Jean-Francois Chenot; Anne Simmenroth-Nayda; Christoph Herrmann-Lingen
Journal:  Psychosoc Med       Date:  2008-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.